Envoy Medical, Inc. (NASDAQ:COCH) Short Interest Update

Envoy Medical, Inc. (NASDAQ:COCH) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 44,400 shares, a growth of 300.0% from the February 29th total of 11,100 shares. Approximately 0.7% of the company’s stock are short sold. Based on an average daily trading volume, of 400,100 shares, the days-to-cover ratio is presently 0.1 days.

Envoy Medical Stock Up 0.3 %

Shares of COCH stock traded up $0.01 during trading on Friday, reaching $3.92. The company’s stock had a trading volume of 80,255 shares, compared to its average volume of 1,092,788. The firm’s fifty day moving average is $3.22. Envoy Medical has a one year low of $0.75 and a one year high of $11.72.

Analyst Ratings Changes

Separately, Northland Securities started coverage on shares of Envoy Medical in a report on Thursday, December 21st. They issued an “outperform” rating for the company.

Institutional Trading of Envoy Medical

An institutional investor recently bought a new position in Envoy Medical stock. Weiss Asset Management LP purchased a new position in shares of Envoy Medical, Inc. (NASDAQ:COCH) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,000 shares of the company’s stock, valued at approximately $37,000. Weiss Asset Management LP owned approximately 0.10% of Envoy Medical at the end of the most recent quarter. 8.59% of the stock is currently owned by hedge funds and other institutional investors.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.